Roche’s emicizumab hemophilia drug shows positive results with children

ZURICH (Reuters) – Roche Holding AG’s emicizumab drug for treating hemophilia A showed positive interim results in a phase III study with children with inhibitors to clotting protein factor VIII, the Swiss drugmaker said on Monday.


Reuters: Health News

Leave a Reply

Your email address will not be published. Required fields are marked *

captcha

Please enter the CAPTCHA text